Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Mikhail Fedorov

Fighting for the 25th Hour: The Biological Limits of Netflix’s Expansion

The stock market's reaction to Netflix's (NFLX) Q1 2026 report looks like a textbook example of dissonance between the fundamental quality of the business and the inflated expectations of speculators. The shares nosedived by almost 10–12% amid, it seemed, brilliant figures.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.